Latest News and Press Releases
Want to stay updated on the latest news?
-
DANBURY, Conn., May 6, 2008 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that Ms. Jennifer L. Good, President and Chief Executive Officer, will be presenting at the...
-
DANBURY, Conn., May 2, 2008 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) announced today that its 2007 Annual Report to Shareholders, including audited financial statements for the...
-
DANBURY, Conn., May 2, 2008 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced its financial results for the first quarter ended March 31, 2008. Total revenues for the...
-
DANBURY, Conn., April 25, 2008 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) will conduct a conference call on Friday, May 2, at 11:00 a.m. EDT to review its financial results for the...
-
DANBURY, Conn., March 12, 2008 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced its financial results for the fourth quarter and full year ended December 31,...
-
DANBURY, Conn., March 11, 2008 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that Jennifer Good, President and Chief Executive Officer of Penwest, will be presenting at...
-
DANBURY, Conn., March 6, 2008 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) will conduct a conference call on Wednesday, March 12, at 11:00 a.m. EDT to review its financial results for...
-
DANBURY, Conn., March 6, 2008 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it has entered into a securities purchase agreement with certain institutional...
-
DANBURY, Conn., Feb. 27, 2008 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that Jennifer Good, President and Chief Executive Officer of Penwest, will be presenting at...
-
DANBURY, Conn., Feb. 4, 2008 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today reported results from the Company's Phase IIa clinical trial evaluating nalbuphine hydrochloride...